Molbio Diagnostics Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)
Molbio Diagnostics Ltd · Outcome · 05 Nov 2026, 11:01 pm
Molbio Diagnostics Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 2,590 (-55.4% YoY | -36.6% QoQ) ■ EBITDA: 439 (-73.9% YoY | -56.3% QoQ) ■ EBITDA Margin (%): 17.0 (-1202 bps YoY | -766 bps QoQ) ■ PAT: 151 (-86.2% YoY | -74.3% QoQ) ■ EPS (INR): 1.33 (-86.3% YoY | -74.5% QoQ)
Original exchange filing (PDF)
More announcements from Molbio Diagnostics Ltd
- Transcript of Earnings Call with analysts and investors for the quarter and half year ended on September 30, 2026 · 11 Nov 2026
- Monitoring Agency Report on the utilization of proceeds raised through issuance of equity shares by way of Public Issue of the Company · 07 Nov 2026
- Audio Recording of Earnings call held on November 05,2026 for the quarter and half year ended September 30,2026. · 06 Nov 2026
- Outcome of Board meeting held on Thursday, November 05, 2026 · 06 Nov 2026
- Investor presentation · 05 Nov 2026
- Outcome of the Board Meeting · 05 Nov 2026
- Intimation of Earnings Conference Call on November 05, 2026, at 05:30 P.M. IST to discuss the financial performance of the Company for the quarter and half year ended September 30, 2026. · 05 Nov 2026
- To consider and approve the Unaudited financial results (Standalone & Consolidated) for the quarter and half year ended September 30, 2026 · 05 Nov 2026
